← Leaderboards
David M. Perlman
University Of Minnesota Twin Cities
$668,790
Attributed
$668,790
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $133.8K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$668,790 · 1
By mechanism
K08$668,790 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Peter B Bitterman$13,879,552
- Dale Sannes Gregerson$10,365,625
- Arthur J Matas$28,561,331
- Marc K. Jenkins$34,351,766
- Cary N Mariash$2,852,105
Others in their field
Top investigators on “Transfection /Expression Vector”
- William W Hauswirth · University Of Florida$14,472,513
- Kenneth G Cornetta · Indiana Univ-Purdue Univ At Indianapolis$10,466,261
- Klaus H. Kaestner · University Of Pennsylvania$8,467,407
- David T Curiel · University Of Alabama At Birmingham$8,321,535
- Timothy A Cross · Florida State University$7,979,166
- John H Wolfe · Children'S Hospital Of Philadelphia$7,103,743
Research focus
Transfection /Expression VectorApoptosisFlow CytometryCell LineBinding SitesGenetic RegulationPolymerase Chain ReactionGenetic TranslationGene ExpressionCell ProliferationMolecular PathologyTrainingMessenger RnaMicroarray TechnologyFibrosisImmunocytochemistryBaseCareerCapping Of MrnaApoptoticAdvisory CommitteesConditionCytotoxic AgentComplex
Grant awards (5)
Identifying Molecular Targets for Anti-Fibrotic Therapy$133,758
K08 · FY2007 · HL · contact PI
Identifying Molecular Targets for Anti-Fibrotic Therapy$133,758
K08 · FY2006 · HL · contact PI
Identifying Molecular Targets for Anti-Fibrotic Therapy$133,758
K08 · FY2005 · HL
Identifying Molecular Targets for Anti-Fibrotic Therapy$133,758
K08 · FY2004 · HL
Identifying Molecular Targets for Anti-Fibrotic Therapy$133,758
K08 · FY2003 · HL